Dellera, Jacinto N.
HRN: 14-04-53 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/12/2024
CEFTRIAXONE 1G (VIAL)
11/12/2024
11/18/2024
IV
2g
OD
CAP-MR; UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractPneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes